“Psoriasis ‘blockbuster’ requires more solid data”, as AbbVie report
Risankizumab showed to be more effective in plaque psoriasis patients than J&J’s Stelara
Source: AbbVie reports more solid data for would-be psoriasis blockbuster
Shared by www.pmgrouplive.com/
AbbVie HOME PAGE >>> www.abbvie.com/
